Literature DB >> 22489794

Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.

Karla Sánchez-Lara1, Jenny G Turcott, Eva Juárez, Patricia Guevara, Carolina Núñez-Valencia, Luis F Oñate-Ocaña, Diana Flores, Oscar Arrieta.   

Abstract

Early identification and treatment of nutritional deficiencies can lead to improved outcomes in the quality of life (QoL) and survival of patients with nonsmall cell lung cancer (NSCLC). Noninvasive techniques are needed to evaluate changes in body composition as part of determining nutritional status. The aim of the study was to evaluate the association of nutritional parameters in health-related quality of life (HRQL) and survival in patients with advanced NSCLC. Chemotherapy-naïve patients with advanced NSCLC with good performance status Eastern Cooperative Oncology Group (ECOG) 0-2 were included prospectively in the study. We evaluated inflammatory parameters such as C-reactive protein, platelet/lymphocyte index, neutrophil/lymphocyte index, serum interleukin (IL)-6, and tumor necrosis factor-α, and nutritional variables such as body mass index (BMI) and serum albumin levels. Bioelectrical impedance analysis including phase angle was obtained before cisplatin-based chemotherapy was started. HRQL was assessed by application of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ)-C30 and QLQ-LC13 instruments at baseline. Overall survival (OS) was calculated with the Kaplan-Meier method and analyzed with log-rank and Cox proportional hazard models. One hundred nineteen patients were included. Mean BMI was 24.8 ± 4.5 kg/m(2), average weight loss of patients was 8.4%, and median phase angle was 5.8°. Malnutrition measured by subjective global assessment (SGA), weight loss >10%, BMI >20 was associated with lower HRQL scales. Patients with ECOG 2, high content serum IL-6, lower phase angle, and malnutrition parameters showed lower OS; however, after multivariate analysis, only ECOG 2 [Hazard ratio (HR), 2.7; 95% confidence interval (95% CI), 1.5-4.7; P = 0.001], phase angle ≤5.8° (HR = 3.02; 95% CI: 1.2-7.11; P = 0.011), and SGA (HR = 2.7; 95% CI, 1.31-5.5; P = 0.005) were associated with poor survival. Patients were divided into low-, intermediate-, and high-risk groups according to regression coefficients; OS at 1 yr was 78.4, 53, and 13.8%, respectively. Malnutrition is associated with low HRQL and is an independent prognostic factor in advanced NSCLC. The results warrant prospective trials to evaluate the impact of different nutritional interventions on HRQL and survival.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489794     DOI: 10.1080/01635581.2012.668744

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  47 in total

1.  Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer.

Authors:  Mehmet Kos; Cemil Hocazade; F Tugba Kos; Dogan Uncu; Esra Karakas; Mutlu Dogan; Hikmet Gulsen Uncu; Nuriye Yildirim; Nurullah Zengin
Journal:  Wien Klin Wochenschr       Date:  2015-02-27       Impact factor: 1.704

2.  Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.

Authors:  Oscar Arrieta; Martha De la Torre-Vallejo; Diego López-Macías; David Orta; Jenny Turcott; Eleazar-Omar Macedo-Pérez; Karla Sánchez-Lara; Laura-Alejandra Ramírez-Tirado; Vickie E Baracos
Journal:  Oncologist       Date:  2015-07-14

3.  Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.

Authors:  Zhen-Qiang He; Chao Ke; Fuad Al-Nahari; Hao Duan; Cheng-Cheng Guo; Yang Wang; Xiang-Heng Zhang; Yin-Sheng Chen; Zhi-Gang Liu; Jian Wang; Zhong-Ping Chen; Xiao-Bing Jiang; Yong-Gao Mou
Journal:  J Neurooncol       Date:  2017-01-11       Impact factor: 4.130

4.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

5.  [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].

Authors:  Ying-Ying Chen; Jia-He Zhang; Wan Zhang; Zi-Ke Yang; Rong-Cheng Luo; Shi-Jun Kang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

6.  The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study.

Authors:  Cindy S Y Tan; Jane A Read; Viet H Phan; Philip J Beale; Jennifer K Peat; Stephen J Clarke
Journal:  Support Care Cancer       Date:  2014-08-13       Impact factor: 3.603

Review 7.  Malnutrition in Older Adults with Cancer.

Authors:  Xiaotao Zhang; Beatrice J Edwards
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

8.  The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial.

Authors:  Jenny G Turcott; María Del Rocío Guillen Núñez; Diana Flores-Estrada; Luis F Oñate-Ocaña; Zyanya Lucia Zatarain-Barrón; Feliciano Barrón; Oscar Arrieta
Journal:  Support Care Cancer       Date:  2018-03-17       Impact factor: 3.603

Review 9.  Gaps in nutritional research among older adults with cancer.

Authors:  Carolyn J Presley; Efrat Dotan; Enrique Soto-Perez-de-Celis; Aminah Jatoi; Supriya G Mohile; Elizabeth Won; Shabbir Alibhai; Deepak Kilari; Robert Harrison; Heidi D Klepin; Tanya M Wildes; Karen Mustian; Wendy Demark-Wahnefried
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

Review 10.  The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review.

Authors:  O Grundmann; S L Yoon; J J Williams
Journal:  Eur J Clin Nutr       Date:  2015-07-29       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.